Authors:
Md. Fazal Karim Department of Hepatology, Dhaka Medical College, Dhaka, Bangladesh

Search for other papers by Md. Fazal Karim in
Current site
Google Scholar
PubMed
Close
,
Mamun Al-Mahtab Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Search for other papers by Mamun Al-Mahtab in
Current site
Google Scholar
PubMed
Close
,
Salimur Rahman Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Search for other papers by Salimur Rahman in
Current site
Google Scholar
PubMed
Close
, and
Mobin Khan Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Search for other papers by Mobin Khan in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract

Treatment of chronic hepatitis B has changed much since the introduction of interferon. Nucleosides have come to replace interferon in some situations like decompensated states. However, there is no clear cut guideline in many fields. Even end of treatment response is low in conventional treatments. This study describes a few scenarios where difficulties were faced. Unresolved questions in the management of chronic hepatitis B involve ‘who to treat, when to treat, how to treat?’ These should be clearly addressed.

  • [1]. L. R. Arosemena R. A. Cortes L. Servin et al.2005 Current and future treatment of chronic hepatitis B Minerva Gastroenterol. Dietol. 51 7793.

    • Search Google Scholar
    • Export Citation
  • [2]. Dusheiko, G., Antonakopoulos, N.: Treatment of hepatitis B. Gut, published 14 May 2007, DOI 10.1136/gut.2005.077891, PMID: 17502343.

    • Search Google Scholar
    • Export Citation
  • [3]. L. D'Antiga Aw. Marion M. Atkins et al.2006 Combined lamivudine/interferon-α treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: a pilot study J. Pediatr. 148 228233.

    • Search Google Scholar
    • Export Citation
  • [4]. G. G. Su K. H. Pan N. F. Zhao et al.2004 Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy World J. Gastroenterol. 10 910912.

    • Search Google Scholar
    • Export Citation
  • [5]. J. H. Hoofnagle E. Doo T. J. Liang et al.2007 Management of hepatitis B: summary of a clinical research workshop Hepatology 45 10561075.

    • Search Google Scholar
    • Export Citation
  • [6]. N. Saikia R. Talukdar S. Mazumder et al.2007 Management of patients with HBeAg-negative chronic hepatitis B Postgrad. Med. J. 83 3239.

    • Search Google Scholar
    • Export Citation
  • [7]. M. Morgan W. Park E. B. Keeffe 2007 Diagnosis and treatment of chronic hepatitis B: an update Minerva Gastroenterol. Dietol. 53 2541.

    • Search Google Scholar
    • Export Citation
  • [8]. G. J. Dore R. Guan S. M. Wasim Jafri et al.2006 Management of chronic hepatitis B in challenging patient populations Liver Int. 26 Suppl.2 3846.

    • Search Google Scholar
    • Export Citation
  • [9]. M. F. Yuen C. L. Lai 2007 Combination therapy for chronic hepatitis B: simultaneous or sequential? Am. J. Gastroenterol. 102 105106.

    • Search Google Scholar
    • Export Citation
  • [10]. A. Ascione T. Ascione A. G. Lanza et al.2006 Factors infl uencing outcome of lamivudine in anti-HBe-positive chronic hepatitis B Hepatogastroenterology 53 919923.

    • Search Google Scholar
    • Export Citation
  • [11]. J. J. Sasadeusz S. L. Locarnini G. Macdonald 2007 Why do we not yet have combination chemotherapy for chronic hepatitis B Med. J. Aust. 186 204206.

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand

Clinical and Experimental Medical Journal
Language English
Size  
Year of
Foundation
2007
Publication
Programme
ceased
Volumes
per Year
 
Issues
per Year
 
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2060-6249 (Print)
ISSN 2060-968X (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Dec 2023 26 2 0
Jan 2024 16 2 2
Feb 2024 3 2 0
Mar 2024 2 0 0
Apr 2024 31 0 0
May 2024 0 0 0
Jun 2024 0 0 0